We are live on ! Find out more
VBIV

VBI Vaccines, Inc. New Common Stock (Canada)
VBIV

Delisted

VBIV was delisted on the 7th of August, 2024.

Back to rankings

43 hedge funds and large institutions have $92M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2019 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 8

11% more capital invested

Capital invested by funds: $82.6M → $92M (+$9.4M)

8% more funds holding

Funds holding: 40 → 43 (+3)

27% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 11

Holders
43
Holders Change
+3
Holders Change %
+7.5%
% of All Funds
0.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
8
Reduced
11
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$1.47M
2
AS
Altshuler Shaham
Israel
+$570K
3
BlackRock
BlackRock
New York
+$348K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$267K
5
TEE
Tibra Equities Europe
United Kingdom
+$203K

Top Sellers

Rank Fund Capital Flow
1
LM
Luminus Management
Texas
-$2.81M
2
MIH
Meitav Investment House
Israel
-$1.07M
3
BI
BVF Inc
California
-$891K
4
CH
CVI Holdings
Delaware
-$585K
5
OAM
Oxford Asset Management
United Kingdom
-$146K

VBIV Hedge Fund Activity: Q1 2019 in Review

43 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) for Q1 2019, worth a combined $92M — up 11% from $82.6M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new VBIV positions and 8 closed out — a net gain of 3 holders — while 8 added to existing stakes and 11 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.47M. The largest seller was Luminus Management, exiting entirely with an estimated $2.81M sold.

  • 43 institutional investors held VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) as of Q1 2019, up from 40 in Q4 2018.
  • Funds reported $92M of VBI Vaccines, Inc. New Common Stock (Canada) stock for Q1 2019, up 11% quarter-over-quarter.
  • 11 funds opened new VBI Vaccines, Inc. New Common Stock (Canada) positions in Q1 2019 and 8 closed out, a net change of +3 holders.
  • The largest VBI Vaccines, Inc. New Common Stock (Canada) buyer in Q1 2019 was Vanguard Group, an estimated $1.47M added.
  • The largest VBI Vaccines, Inc. New Common Stock (Canada) seller in Q1 2019 was Luminus Management, an estimated $2.81M sold.

Based on aggregated 13F filings for Q1 2019.